OXAZEPAM Drug Patent Profile
✉ Email this page to a colleague
When do Oxazepam patents expire, and when can generic versions of Oxazepam launch?
Oxazepam is a drug marketed by Actavis Elizabeth, Am Therap, Epic Pharma Llc, Ivax Sub Teva Pharms, Mylan, United Res Labs, Watson Labs, Watson Labs Teva, Parke Davis, and Sun Pharm Industries. and is included in twenty NDAs.
The generic ingredient in OXAZEPAM is oxazepam. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the oxazepam profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Oxazepam
A generic version of OXAZEPAM was approved as oxazepam by UNITED RES LABS on August 10th, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OXAZEPAM?
- What are the global sales for OXAZEPAM?
- What is Average Wholesale Price for OXAZEPAM?
Summary for OXAZEPAM
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 20 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 43 |
| Clinical Trials: | 15 |
| Patent Applications: | 5,022 |
| Drug Prices: | Drug price information for OXAZEPAM |
| DailyMed Link: | OXAZEPAM at DailyMed |
Recent Clinical Trials for OXAZEPAM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Assistance Publique - Hôpitaux de Paris | Phase 2 |
| Embera NeuroTherapeutics, Inc. | Phase 1/Phase 2 |
| Rose Research Center, LLC | Phase 1/Phase 2 |
Pharmacology for OXAZEPAM
| Drug Class | Benzodiazepine |
Medical Subject Heading (MeSH) Categories for OXAZEPAM
Anatomical Therapeutic Chemical (ATC) Classes for OXAZEPAM
US Patents and Regulatory Information for OXAZEPAM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Elizabeth | OXAZEPAM | oxazepam | CAPSULE;ORAL | 072253-002 | Apr 14, 1988 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| United Res Labs | OXAZEPAM | oxazepam | CAPSULE;ORAL | 071026-001 | Aug 10, 1987 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs | OXAZEPAM | oxazepam | TABLET;ORAL | 071494-001 | Apr 21, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Epic Pharma Llc | OXAZEPAM | oxazepam | CAPSULE;ORAL | 071813-001 | Apr 19, 1988 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Am Therap | OXAZEPAM | oxazepam | CAPSULE;ORAL | 071955-001 | Mar 3, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
